MEETING OBJECTIVES

Support physicians who have the opportunity to treat MM patients with IMiD® agents and provide confidence through understanding and discussion of currently available trial data and best clinical practice

Educate physicians in managing AEs, patient compliance and quality of life during continuous MM treatment

Present a programme that allows for meaningful debate on scientific/clinical questions and treatment options for MM patients